DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Chunhong Hu(Central South University), Fang Wu(Central South University), Yue Zeng(The University of Texas MD Anderson Cancer Center), Junqi Liu(First Affiliated Hospital of Zhengzhou University), Xiaohan Liu(Central South University)
Cited by 253
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
|Frontiers in Oncology|2021|111
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
|Diabetes Research and Clinical Practice|2014|92
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
|Frontiers in Cell and Developmental Biology|2021|78